1. Home
  2. XBIT vs WYY Comparison

XBIT vs WYY Comparison

Compare XBIT & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.95

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Logo WidePoint Corporation

WYY

WidePoint Corporation

N/A

Current Price

$5.91

Market Cap

62.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
WYY
Founded
2005
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
57.6M
62.9M
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
XBIT
WYY
Price
$1.95
$5.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
82.6K
★ 122.0K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $150,545,364.00
Revenue This Year
N/A
$12.26
Revenue Next Year
$30.47
$25.66
P/E Ratio
★ N/A
$617.00
Revenue Growth
N/A
★ 5.59
52 Week Low
$1.80
$3.96
52 Week High
$2.73
$24.30

Technical Indicators

Market Signals
Indicator
XBIT
WYY
Relative Strength Index (RSI) 45.36 34.96
Support Level $1.83 $5.60
Resistance Level $2.42 $7.74
Average True Range (ATR) 0.11 0.42
MACD 0.01 -0.01
Stochastic Oscillator 45.45 8.33

Price Performance

Historical Comparison
XBIT
WYY

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: